COVID-19

Sales & Marketing

Gitte Aabo on telemedicine and GN Hearing: the pharmaphorum ...

Joining the pharmaphorum podcast for episode 24 is Gitte Aabo, who last year moved to hearing aid technology firm GN Hearing as CEO.

News

FDA slams brakes on Inovio's final-stage COVID-19 vaccine tr...

Inovio Pharma’s plan to start pivotal testing of its COVID-19 vaccine has been delayed by FDA requests for more information, sending its shares into a swift decline.

News

Charities bankroll coronavirus drug hunt as outbreak hits economies

UK has no plans to buy rapid COVID-19 test favoured by US an...

The US and some of the world’s poorest countries may get a low-cost and rapid COVID-19 test ahead of the UK, after the government said it had no immediate plans to order them from manufactu

News

UK pledges £571m to equitable COVID-19 vaccine access scheme

UK Prime Minister Boris Johnson has told the UN General Assembly that the UK will donate £571 million ($735 million) to the COVAX scheme aimed at distributing COVID-19 vaccines fairly aroun

News

"Tokyo, Japan - May 11, 2012: Pfizer building on May 11, 2012 in Tokyo. Pfizer is one of largest pharmaceutical companies worldwide with tremendous revenue $67.4 bn USD for 2011. It exists since 1849."

Scientists urge Pfizer to delay COVID-19 vaccine filing

A group of leading scientists have urged Pfizer to wait until at least late November before asking for the FDA to authorise its potential COVID-19 vaccine, to double-check its safety.

News

Novavax begins late-stage trial of COVID-19 vaccine in the U...

Novavax has begun a late-stage trial of its experimental COVID-19 vaccine in the UK, which could support filings for a licence in the UK, EU and other countries.

Gitte Aabo on telemedicine and GN Hearing: the pharmaphorum ...

FDA slams brakes on Inovio's final-stage COVID-19 vaccine tr...

UK has no plans to buy rapid COVID-19 test favoured by US an...

UK pledges £571m to equitable COVID-19 vaccine access scheme

Scientists urge Pfizer to delay COVID-19 vaccine filing

Novavax begins late-stage trial of COVID-19 vaccine in the U...

Immunovant's thyroid eye disease drug flunks pivotal trials

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks